Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
05/22/2003 | WO2003042366A2 A novel saitohin gene and uses of same |
05/22/2003 | WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
05/22/2003 | WO2003042359A2 Histamine receptor h3 polynucleotides |
05/22/2003 | WO2003042357A2 Enzymes |
05/22/2003 | WO2003042249A2 Peptide purification by means of metal ion affinity chromatography |
05/22/2003 | WO2003042245A2 Growth hormone variations in humans and their uses |
05/22/2003 | WO2003042240A2 Polypeptides of pseudomonas aeruginosa |
05/22/2003 | WO2003041830A2 Macroporous gel, its preparation and its use |
05/22/2003 | WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/22/2003 | WO2003020763A3 Soluble t cell receptor |
05/22/2003 | WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
05/22/2003 | WO2003004652A3 Use of a tyrosine recombinase for genetic engineering |
05/22/2003 | WO2002102836A3 Moraxella (branhamella) catarrhalis antigens |
05/22/2003 | WO2002068653A3 Tri-hybrid melanoma antigen |
05/22/2003 | WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/22/2003 | WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
05/22/2003 | WO2002040690A3 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
05/22/2003 | WO2002036780A3 Stearoyl-coa desaturase gene promoter |
05/22/2003 | WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
05/22/2003 | WO2002018617A3 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria |
05/22/2003 | WO2001068708A9 Human and humanized fap-alpha-specific antibodies |
05/22/2003 | WO2001015736A3 Interferon-beta conjugates |
05/22/2003 | US20030097667 For therapy of Alzheimers disease, diagnosis |
05/22/2003 | US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders |
05/22/2003 | US20030096973 Recombinant collagens and derived proteins produced by plants, methods of obtaining such and their uses |
05/22/2003 | US20030096956 Process for producing kiss-1 peptide |
05/22/2003 | US20030096790 Bacterial antigens for an immunological test for infection of by a Grampositive bacterium; diagnosing infection associated with central venous catheters, prosthetic devices, and cerebrospinal fluid shunts |
05/22/2003 | US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
05/22/2003 | US20030096749 Human cytokine receptor |
05/22/2003 | US20030096746 Compounds and methods for inhibiting cancer metastasis |
05/22/2003 | US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/22/2003 | US20030096414 Culture medium for cell growth and transfection |
05/22/2003 | US20030096412 Method of preparing biological materials for cryopreservation using pre-chilled protectant |
05/22/2003 | US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
05/22/2003 | US20030096385 High production method of prenyl alcohol by microorganisms |
05/22/2003 | US20030096381 Production of polyketides |
05/22/2003 | US20030096380 Microorganisms and processes for producing L-glutamine |
05/22/2003 | US20030096376 Generation of autoinducer-2; obtain S-adenosylhomocysteine, incubate with preferential protein, allow conversion of s-adenosylhomocysteine to autoinducer-2 |
05/22/2003 | US20030096375 Methods and compositions for production of lipo-chito oligosaccharides by rhizobacteria |
05/22/2003 | US20030096374 Synthesis of oligoketides |
05/22/2003 | US20030096371 Human cytokines |
05/22/2003 | US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection |
05/22/2003 | US20030096369 Non-anaphylactogenic IgE vaccines |
05/22/2003 | US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections |
05/22/2003 | US20030096365 Biochemical and genetic characterization of propionicin T1 |
05/22/2003 | US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease |
05/22/2003 | US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease |
05/22/2003 | US20030096349 N4 virion single-stranded DNA dependent RNA polymerase |
05/22/2003 | US20030096348 DNA molecules encoding mammalian nuclear receptor protein, nNR5 |
05/22/2003 | US20030096345 15569, a novel human G protein coupled receptor and uses therefor |
05/22/2003 | US20030096342 Mixture containing glucanase for use in degradation of plant biomass and pollution control |
05/22/2003 | US20030096341 Generation of preferential enzymatic polypeptide in eukaryote; obtain vector, minsert clone, transfrom eukaryotic cell, expres vector, purify polypeptide |
05/22/2003 | US20030096338 Protein conjugate for use in the treatment of blood disorder |
05/22/2003 | US20030096335 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds |
05/22/2003 | US20030096330 Genetically engineered cell for use as tool in controlling bacterial propagation and infection |
05/22/2003 | US20030096323 Detecting phosphodiesterase inhibitor; obtain cell, incubate with modulator, monitor expression of cyclic adenine and guanine monophosphates, compare to control, reduction in concentrations indicate inhibitor |
05/22/2003 | US20030096313 Novel serine-threonine kinase-4 |
05/22/2003 | US20030096312 Novel natrium-calcium exchanger protein |
05/22/2003 | US20030096282 Gtpase-activating protein 1 |
05/22/2003 | US20030096267 Essential bacterial genes and their use |
05/22/2003 | US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals |
05/22/2003 | US20030096245 Invasive cleavage of nucleic acids |
05/22/2003 | US20030096037 Ferment activator based on lactic acid bacteria and method for preparing a dairy product using same |
05/22/2003 | US20030096029 Remedies for allergic diseases and process for producing the same |
05/22/2003 | US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof |
05/22/2003 | US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists. |
05/22/2003 | CA2784450A1 Polypeptides of pseudomonas aeruginosa |
05/22/2003 | CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
05/22/2003 | CA2473141A1 Macroporous gel, its preparation and its use |
05/22/2003 | CA2468171A1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
05/22/2003 | CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
05/22/2003 | CA2467347A1 Histamine receptor h3 polynucleotides |
05/22/2003 | CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
05/22/2003 | CA2466420A1 A novel saitohin gene and uses of same |
05/22/2003 | CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor |
05/22/2003 | CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/22/2003 | CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
05/22/2003 | CA2463639A1 Growth hormone variations in humans and their uses |
05/22/2003 | CA2460959A1 Enzymes |
05/22/2003 | CA2454031A1 Novel chromophores/fluorophores and methods for using the same |
05/21/2003 | EP1312920A1 Method of screening remedy for heart failure |
05/21/2003 | EP1312679A1 Recombinant MVA virus, and the use thereof |
05/21/2003 | EP1312678A1 Recombinant MVA virus, and the use thereof |
05/21/2003 | EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
05/21/2003 | EP1312371A1 Animal papilla disinfectants and method of improving microbial environment |
05/21/2003 | EP1312263A1 Method for producing working reagent and for biological prevention or control |
05/21/2003 | EP1311708A1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
05/21/2003 | EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
05/21/2003 | EP1311692A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
05/21/2003 | EP1311685A2 Nucleotide sequences which code for the ccpa1 gene |
05/21/2003 | EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
05/21/2003 | EP1311683A1 Nucleotide sequences which code for the csta gene from corynebacterium glutamicum |
05/21/2003 | EP1311680A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
05/21/2003 | EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
05/21/2003 | EP1311678A2 Cripto tumour polypeptide |
05/21/2003 | EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor |
05/21/2003 | EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor |
05/21/2003 | EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
05/21/2003 | EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor |
05/21/2003 | EP1311665A2 Kidney-specific protein |